Novartis | Umlaufvermögen



Current Assets Veränderung Datum
AbbVie USD 27.68B 2.09B 2025-03
Alcon AG USD 6.07B 242M 2025-03
Almirall EUR 714.05M 50.55M 2025-06
Amgen USD 26.73B 195M 2025-06
AstraZeneca USD 28.94B 2.8B 2025-06
Autolus Therapeutics Ltd 574.25M 41.52M 2025-06
Bayer EUR 33.75B 1.08B 2025-06
Biogen USD 7.97B 341.7M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Eli Lilly USD 49.85B 8.59B 2025-06
Fresenius EUR 10.88B 1.03B 2025-06
Fresenius Medical Care EUR 8.14B 178.09M 2025-06
Galapagos EUR 3.26B 217.04M 2025-06
Genmab DKK 3.91B 127M 2025-06
Gilead Sciences USD 14.72B 2.18B 2025-06
GlaxoSmithKline GBP 17.67B 412M 2025-06
GRIFOLS EUR 5.25B 393.8M 2025-06
Hikma Pharmaceutical USD 2.26B 22M 2024-12
J&J USD 71.55B 15.66B 2025-03
Lonza CHF 5.44B 113M 2024-12
Merck EUR 12.2B 216M 2025-06
Merck USD 37.07B 1.56B 2025-06
Novartis USD 25.94B 831M 2025-06
Novartis USD 29.7B 1.56B 2024-12
Novo Nordisk 162.71B 11.69B 2025-06
Orion EUR 1.01B 76.5M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
Philips EUR 9.06B 394M 2025-06
Recordati EUR 1.57B 3.62M 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 37.02B 7B 2025-06
UCB EUR 4.79B 1.47B 2024-12


Novartis Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.